ARIELE POLLACK: Open Payments
NPI 1386256154 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,587 in 110 payments from 30 companies in 2025. Trend: 2023 $2,705 · 2024 $2,714 · 2025 $2,587
Food & beverage: $2,512Education: $75
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 9 | $357 |
| Daiichi Sankyo Inc. | 10 | $281 |
| Eisai Inc. | 14 | $228 |
| Astellas Pharma US Inc | 5 | $175 |
| Genmab U.S., Inc. | 10 | $148 |
| PFIZER INC. | 5 | $114 |
| Novartis Pharmaceuticals Corporation | 4 | $107 |
| Merck Sharp & Dohme LLC | 4 | $103 |
| TAIHO ONCOLOGY, INC. | 5 | $102 |
| Gilead Sciences, Inc. | 5 | $95 |
Products named: Enhertu, Lenvima, RYBREVANT, TALVEY, Tivdak, LONSURF, Vyloy, Trodelvy.
Industry payments across NY — which companies pay providers there.
